SCHEMBL30165735

SCHEMBL30165735

COc1cc(CC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 20/20 0.83
INSR P06213 19/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25566208 1.00 ALK (0.83) ALKINSR
SCHEMBL20085715 0.91 ALK (1.00) ALKINSR
SCHEMBL4453827 0.90 ALK (0.68) ALKINSR
SCHEMBL30180103 0.90 ALK (0.85) ALKINSR
SCHEMBL20085710 0.90 ALK (1.00) ALKINSR
SCHEMBL20085717 0.89 ALK (1.00) ALKINSR
SCHEMBL20085706 0.89 INSR (1.00) ALKINSR
SCHEMBL20085714 0.89 ALK (1.00) ALKINSR
SCHEMBL20085697 0.89 ALK (1.00) ALKINSR
SCHEMBL20085713 0.89 ALK (1.00) ALKINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4362939-A1 BIFUNCTIONAL COMPOUNDS THAT DEGRADE ALK AND USES THEREOF Dana-Farber Cancer Institute, Inc. (US) 2024-05-08 EP disclosed
WO-2023278325-A1 BIFUNCTIONAL COMPOUNDS THAT DEGRADE ALK AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-01-05 WO disclosed
EP-4110340-A1 POTENT AND SELECTIVE DEGRADERS OF ALK Dana-Farber Cancer Institute, Inc. (US) 2023-01-04 EP disclosed